perampanel 2 MG 2-Week Sample Kit

RxCUI
2641918
RxNorm name
perampanel 2 MG 2-Week Sample Kit
Display name
perampanel 2 MG 2-Week Sample Kit
Full name
perampanel 2 MG 2-Week Sample Kit
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FycompaPERAMPANELCatalyst Pharmaceuticals, Inc.ec812ea3-de3a-4271-957c-db8f692d1ae32024-01-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2641918

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ec812ea3-de3a-4271-957c-db8f692d1ae3perampanel 2 MG 2-Week Sample KitSY4These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) tablets, for oral use, CIII FYCOMPA ® (perampanel) oral suspension, CIII Initial U.S. Approval: 201220240105
ec812ea3-de3a-4271-957c-db8f692d1ae3{14 (perampanel 2 MG Oral Tablet) } PackGPCK4These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) tablets, for oral use, CIII FYCOMPA ® (perampanel) oral suspension, CIII Initial U.S. Approval: 201220240105
ec812ea3-de3a-4271-957c-db8f692d1ae3perampanel 2 MG 2-Week Sample KitPSN4These highlights do not include all the information needed to use FYCOMPA ® safely and effectively. See full prescribing information for FYCOMPA ® . FYCOMPA ® (perampanel) tablets, for oral use, CIII FYCOMPA ® (perampanel) oral suspension, CIII Initial U.S. Approval: 201220240105